KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Revenue: 2009-2025

Historic Revenue for Idexx Laboratories (IDXX) over the last 17 years, with Sep 2025 value amounting to $1.1 billion.

  • Idexx Laboratories' Revenue rose 13.29% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.2 billion, marking a year-over-year increase of 8.39%. This contributed to the annual value of $3.9 billion for FY2024, which is 6.46% up from last year.
  • Per Idexx Laboratories' latest filing, its Revenue stood at $1.1 billion for Q3 2025, which was down 0.38% from $1.1 billion recorded in Q2 2025.
  • Idexx Laboratories' Revenue's 5-year high stood at $1.1 billion during Q2 2025, with a 5-year trough of $777.7 million in Q1 2021.
  • Over the past 3 years, Idexx Laboratories' median Revenue value was $964.1 million (recorded in 2024), while the average stood at $979.2 million.
  • Data for Idexx Laboratories' Revenue shows a peak YoY increased of 29.57% (in 2021) over the last 5 years.
  • Idexx Laboratories' Revenue (Quarterly) stood at $801.1 million in 2021, then grew by 3.43% to $828.6 million in 2022, then climbed by 8.81% to $901.6 million in 2023, then increased by 5.84% to $954.3 million in 2024, then rose by 13.29% to $1.1 billion in 2025.
  • Its Revenue stands at $1.1 billion for Q3 2025, versus $1.1 billion for Q2 2025 and $998.4 million for Q1 2025.